Focus Partners Advisor Solutions LLC Trims Stock Holdings in Intuitive Surgical, Inc. $ISRG

Focus Partners Advisor Solutions LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,706 shares of the medical equipment provider’s stock after selling 71 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in Intuitive Surgical were worth $2,013,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chilton Capital Management LLC raised its stake in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical in the first quarter worth $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical in the first quarter worth $30,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical in the first quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $546.51 on Monday. The company has a market cap of $195.91 billion, a P/E ratio of 72.29, a PEG ratio of 5.02 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business’s 50-day simple moving average is $458.09 and its 200 day simple moving average is $497.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue was up 22.9% on a year-over-year basis. During the same period last year, the business posted $1.84 EPS. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on ISRG. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a report on Wednesday. Leerink Partners increased their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Evercore ISI decreased their price target on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 7th. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Finally, Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $602.32.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 30,031 shares of company stock valued at $14,177,895. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.